Citadel Advisors - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 53 filers reported holding CENTURY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$124,782
+52.2%
62,391
+140.5%
0.00%
Q2 2023$81,986
-60.8%
25,945
-57.0%
0.00%
Q1 2023$209,241
-78.9%
60,300
-68.8%
0.00%
Q4 2022$991,927
+64.0%
193,358
+215.9%
0.00%
Q3 2022$605,000
+20.0%
61,200
+2.1%
0.00%
Q2 2022$504,000
+23.2%
59,966
+84.7%
0.00%
Q1 2022$409,000
-32.4%
32,458
+35.0%
0.00%
Q3 2021$605,00024,0440.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 602,623$15,162,0003.73%
Casdin Capital, LLC 3,206,380$80,673,0002.01%
Logos Global Management LP 639,095$16,080,0001.16%
Parametrica Management Ltd 28,755$723,0000.54%
DAFNA Capital Management LLC 80,000$2,013,0000.53%
Avidity Partners Management LP 739,269$18,600,0000.41%
RA Capital Management 914,094$22,999,0000.32%
HHLR ADVISORS, LTD. 614,095$15,451,0000.20%
Orbimed Advisors 407,047$10,241,0000.11%
Woodline Partners LP 250,094$6,292,0000.10%
View complete list of CENTURY THERAPEUTICS INC shareholders